HALO
HALOZYME THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$130.34
+1.34%Forward multiples
Based on analyst estimates
- P/E forward
- 13.06x
- P/E 2026E
- 14.88x
- P/E 2027E
- 12.32x
- P/E 2028E
- 10.61x
- P/S forward
- 7.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.03x
- PEG TTM
- 0.20x
- Price / book
- 103.06x
- Price / sales
- 8.89x
- Price / cash flow
- 18.07x
Enterprise value
- Enterprise value
- $16.7B
- EV / sales
- 10.04x
- EV / EBITDA
- 23.26x
- EV / EBIT
- 17.95x
- Market cap
- $14.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026